These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10418756)

  • 1. A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections.
    de Klerk GJ; van Steijn JH; Lobatto S; Jaspers CA; van Veldhuizen WC; Hensing CA; Bunnik MC; Geraedts WH; Dofferhof AS; Van Den Berg J; Melis JH; Hoepelman AI
    Int J Antimicrob Agents; 1999 Jul; 12(2):121-7. PubMed ID: 10418756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
    Wessels F; Anderson AN; Ebrahim O
    S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
    Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
    Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin for acute lower respiratory tract infections.
    Panpanich R; Lerttrakarnnon P; Laopaiboon M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD001954. PubMed ID: 15497172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia.
    Dresser LD; Niederman MS; Paladino JA
    Chest; 2001 May; 119(5):1439-48. PubMed ID: 11348951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
    Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of once-daily cephalosporin regimens for community-acquired lower respiratory tract infections in patients with chronic lung disease.
    McCabe RE; Schlossberg D; Donowitz GR; Scheld WM; Zellner SR; Lindenberg LB; Armstrong JH; Ein ME
    Clin Ther; 1989; 11(3):304-14. PubMed ID: 2663160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
    Gao B; Hu J; Deng W
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):528-31. PubMed ID: 11360502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
    Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
    Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T; Jakobs R; Riemann JF
    Hepatogastroenterology; 2004; 51(58):941-5. PubMed ID: 15239219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of severe lower respiratory tract infections with ceftriaxone (Ro 13-9904). A pilot study.
    Keller R; Humair L
    Chemotherapy; 1981; 27 Suppl 1():93-9. PubMed ID: 7249798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections.
    Hirata-Dulas CA; Stein DJ; Guay DR; Gruninger RP; Peterson PK
    J Am Geriatr Soc; 1991 Oct; 39(10):979-85. PubMed ID: 1918785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One dose ceftriaxone vs. ten days of amoxicillin/clavulanate therapy for acute otitis media: clinical efficacy and change in nasopharyngeal flora.
    Cohen R; Navel M; Grunberg J; Boucherat M; Geslin P; Derriennic M; Pichon F; Goehrs JM
    Pediatr Infect Dis J; 1999 May; 18(5):403-9. PubMed ID: 10353511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ceftibuten once daily and amoxicillin-clavulanate three times daily in the treatment of acute exacerbations of chronic bronchitis.
    McAdoo MA; Rice K; Gordon GR; Sahn SA
    Clin Ther; 1998; 20(1):88-100. PubMed ID: 9522107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.
    Hoepelman IM; Möllers MJ; van Schie MH; Greefhorst AP; Schlösser NJ; Sinninghe Damsté EJ; van de Moosdijk CN; Dalinghaus WH; Eland ME; Mol SJ; Rozenberg-Arska M
    Int J Antimicrob Agents; 1997 Jan; 9(3):141-6. PubMed ID: 9552709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis.
    Léophonte P; Baldwin RJ; Pluck N
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):434-40. PubMed ID: 9758289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of anti-inflammatory or antibiotic treatment in patients with non-complicated acute bronchitis and discoloured sputum: randomised placebo controlled trial.
    Llor C; Moragas A; Bayona C; Morros R; Pera H; Plana-Ripoll O; Cots JM; Miravitlles M
    BMJ; 2013 Oct; 347():f5762. PubMed ID: 24097128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia.
    Paladino JA; Eubanks DA; Adelman MH; Schentag JJ
    J Am Geriatr Soc; 2007 May; 55(5):651-7. PubMed ID: 17493183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
    Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
    J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.